Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway-Reference-Cited by-同舟云学术

Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

Published:2011-06-18 Issue:4 Volume:130 Page:967-978
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Yeramian Andree,Sorolla Anabel,Velasco Ana,Santacana Maria,Dolcet Xavier,Valls Joan,Abal Leandre,Moreno Sara,Egido Ramón,Casanova Josep M.,Puig Susana,Vilella Ramón,Llombart-Cussac Antonio,Matias-Guiu Xavier,Martí Rosa M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Molecular pathogenesis of cutaneous melanocytic neoplasms;Ibrahim;Annu Rev Pathol,2009

2. KIT as a therapeutic target in melanoma;Garrido;J Invest Dermatol,2010

3. Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics;Woodman;Biochem Pharmacol,2010

4. Inhibition of mutated, activated BRAF in metastatic melanoma;Flaherty;N Engl J Med,2010

5. Targeted therapy in melanoma;Tawbi;Biologics,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenesis Still Plays a Crucial Role in Human Melanoma Progression;Cancers;2024-05-08

2. The role of angiogenesis in melanoma: Clinical treatments and future expectations;Frontiers in Pharmacology;2022-12-15

3. Sunitinib malate inhibits hemangioma cell growth and migration by suppressing focal adhesion kinase signaling;Journal of Applied Biomedicine;2020-12-14

4. Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment;Expert Opinion on Drug Delivery;2020-09-11

5. From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds;Biomolecules;2020-02-06